Literature DB >> 15580217

Clinically evident venous thromboembolic events in children with brain tumors.

Steven R Deitcher1, Amar Gajjar, Larry Kun, Richard L Heideman.   

Abstract

We evaluated the incidence and significance of central venous access device dysfunction and symptomatic major thrombosis in 253 pediatric patients with brain tumors. Central venous access device dysfunction was a common complication (28.4%) and was associated with major thrombosis development and a reduced overall survival rate. Major thrombosis was relatively uncommon (2.8%).

Entities:  

Mesh:

Year:  2004        PMID: 15580217     DOI: 10.1016/j.jpeds.2004.05.055

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  Pediatric stroke.

Authors:  Javier F Cárdenas; Jong M Rho; Adam Kirton
Journal:  Childs Nerv Syst       Date:  2011-02-20       Impact factor: 1.475

2.  Catheter-Related Complications in Children With Cancer Receiving Parenteral Nutrition: Change in Risk Is Moderated by Catheter Type.

Authors:  Melissa A Shenep; Mary R Tanner; Yilun Sun; Tina Culley; Randall T Hayden; Patricia M Flynn; Li Tang; Joshua Wolf
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-01-07       Impact factor: 4.016

3.  Brain neoplasms and coagulation-lessons from heterogeneity.

Authors:  Esterina D'Asti; Yi Fang; Janusz Rak
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

Review 4.  Venous Thromboembolism in Children with Cancer and Blood Disorders.

Authors:  Richard H Ko; Courtney D Thornburg
Journal:  Front Pediatr       Date:  2017-02-06       Impact factor: 3.418

5.  Thrombosis and Anticoagulant Therapy Among Pediatric Cancer Patients: Real-Life Data.

Authors:  Hasan Hashem; Momen Zeineddin; Rayan Bater; Nisreen Amayiri; Wiam Al Qasem; Bilasan Hammo; Iyad Sultan; Rama AlMasri; Hikmat Abdel-Razeq
Journal:  Cureus       Date:  2021-12-01

6.  Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?

Authors:  Jacqueline Halton; Kim Nagel; Leonardo R Brandão; Mariana Silva; Paul Gibson; Anthony Chan; Kay Blyth; Kim Hicks; Nagina Parmar; Leslie Paddock; Stephanie Willing; Lehana Thabane; Uma Athale
Journal:  BMC Cancer       Date:  2012-07-26       Impact factor: 4.430

7.  Monitoring Central Venous Catheter Resistance to Predict Imminent Occlusion: A Prospective Pilot Study.

Authors:  Joshua Wolf; Li Tang; Jeffrey E Rubnitz; Rachel C Brennan; David R Shook; Dennis C Stokes; Paul Monagle; Nigel Curtis; Leon J Worth; Kim Allison; Yilun Sun; Patricia M Flynn
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.